SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending as investors are digesting news of a significant AI hosting agreement with Fluidstack, which includes backing from Google; the community is weighing the long-term potential against concerns about near-term dilution from a proposed convertible note offering. Discussions revolve around the company's strategic shift from Bitcoin mining to AI data centers and the implications of Google's involvement and potential for future deals. Some traders point out the growth potential of the sector while others express concerns about near-term price action.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending amid discussions around its high valuation compared to competitors like CarMax, with community members pointing to insider selling and subprime lending practices. Some traders are anticipating a continued pump, while others believe the stock is overvalued and due for a correction, especially in light of CarMax's recent performance and concerns about Carvana's loan portfolio. The stock's unusual price action and the potential impact of future interest rate decisions are also being closely monitored.

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is gaining traction as a community-driven meme coin inspired by Grok's AI dog character, with some speculating about possible ties to Elon Musk's xAI initiatives. The community emphasizes the project's decentralized nature, highlighting that the liquidity pool is burned and the contract is renounced. Many members express strong conviction in its long-term potential within the crypto AI market.

China Natural Resources, Inc. is an investment holding company. The firm is primarily involved in the exploration and mining in the People’s Republic of China (PRC). It is engaged in the exploration for lead, silver, and other metals, and copper trading in the Inner Mongolia Autonomous Region of the PRC. The company was founded on December 14, 1993 and is headquartered in Hong Kong.

China Natural Resources Inc

China Natural Resources is trending due to its pursuit of a lithium mine acquisition in Zimbabwe, sparking excitement among investors. The community is discussing the stock's low float and potential for a significant run, drawing parallels to other lithium plays. Zero borrow availability is also adding to the bullish sentiment.

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.

PepGen Inc

PepGen is trending due to discussions around a recent public offering of shares, alongside positive clinical trial results for their DM1 drug which showed a significant splicing correction. The community is debating the impact of the dilution from the offering versus the potential of the clinical data and analyst upgrades. Short squeeze potential is also being discussed.

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.

SciSparc Ltd

Scisparc Ltd

SPRC is trending due to news regarding a court stay on its merger with AutoMax Motors, extending the deadline to September 2025, which is causing volatility as the community debates the potential outcomes. The stock's low float and high short interest are also contributing to the intense trading activity, with some traders anticipating a short squeeze. SPRC's association with both the automotive sector and biotech (quantum computing initiative) adds to the speculative interest.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is trending as investors digest news of a settlement with the FTC regarding Prime subscriptions, with the community debating its impact. Bullish sentiment is fueled by an upgrade from Wells Fargo citing strong AWS growth potential and AI investments. Some traders anticipate catalysts related to upcoming events and potential breakouts, while others remain skeptical, pointing to recent underperformance.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the implications of ongoing legal battles and potential legislative solutions regarding reimbursement for Xphozah, while also weighing positive sales momentum for Ibsrela. Community members are actively discussing upcoming conferences, recent insider trading activity, and debating the stock's potential trajectory amidst low trading volume. Some are expressing optimism about positive prescription data, potential partnership deals and the possibility of a positive court outcome.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the stock price fluctuates, impacted by Bitcoin's movements and potential dilution concerns. The community is actively discussing technical levels, potential short squeezes, and the overall correlation between the stock and Bitcoin. Some traders express frustration with the stock's performance, while others see it as a leveraged play on Bitcoin's future.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is trending as investors react to broader sector news, including potential government initiatives to support rare earth mining and processing, as well as rising rare earth prices. The community is discussing the company's strategic importance in the U.S. supply chain and its potential for further growth, as well as the potential impact of developments with other companies in the sector. Discussions also include the stock's technical indicators and potential price movements.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome

SciSparc secures FDA approval for Phase IIb clinical trial of SCI-110, targeting unmet needs in Tourette Syndrome, Global trial begins soon.
read more...

Clearmind Medicine Files International Patent For Ibogaine Combination Therapy

Clearmind Medicine filed an international patent for a treatment that aims to enhance addiction treatment safety and efficacy.
read more...

SciSparc and Clearmind Innovate in Mental Health Therapy

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a pharmaceutical company specializing in central nervous system disorders, has revealed...

SciSparc Initiates Groundbreaking Autism Therapy Trial

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a pharmaceutical firm focused on central nervous system disorders, has launched a clini...

Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy

SciSparc signs an exclusive license agreement with Polyrizon Ltd for its SCI-160 pain treatment program, with potential milestones of $3M in cash plus royalties.
read more...

SciSparc Eyes $6M Deal for Pain Treatment License

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a clinical-stage pharmaceutical company, has announced a non-binding letter of intent t...

SciSparc Ltd. Faces Nasdaq Delisting Over Bid Price

SciSparc Ltd. (SPRC) has released an update. SciSparc Ltd., a biopharmaceutical firm focusing on central nervous system disorders, has been notifie...

Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression

Vancouver, Canada, March 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY) ( Clearmind or the company ), a biotech company focused on discovery and development of...

SciSparc says Clearmind submits international patent application for depression

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

TEL AVIV, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...

Will Costco Wholesale ($COST) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

Stocktwits

Costco Wholesale Corp

) beat its quarterly EPS estimate? 
 
*Powered by Polymarket

SPRC
Scisparc Ltd

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest SPRC News

SPRC Scisparc Ltd